Innoviva (INVA) Interest & Investment Income (2010 - 2021)
Innoviva (INVA) posted Interest & Investment Income of $503000.0 for Q3 2021, up 2415.0% on a QoQ basis from $20000.0 in Q2 2021, and up 1126.83% year-over-year from $41000.0 in Q3 2020.
Innoviva (INVA) Interest & Investment Income (2010 - 2021) Analysis & Trends
Innoviva's Interest & Investment Income history runs 12 years deep, the most recent figure standing at $503000.0 for Q3 2021.
- Quarterly Interest & Investment Income rose 1126.83% year-over-year to $503000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $576000.0 (down 81.05% YoY) and the FY2020 annual result came in at $1.5 million, down 72.49% from the prior year.
- Interest & Investment Income was $503000.0 for Q3 2021 at Innoviva, up from $20000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.6 million in Q3 2019 and bottomed at $20000.0 in Q2 2021.
- A 5-year average of $557263.2 and a median of $380000.0 in 2018 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2020 — Interest & Investment Income sank 98.5% — and 2021, when it soared 1126.83%.
- Innoviva's Interest & Investment Income stood at $393000.0 in 2017, then soared by 32.06% to $519000.0 in 2018, then soared by 196.34% to $1.5 million in 2019, then sank by 98.5% to $23000.0 in 2020, then jumped by 2086.96% to $503000.0 in 2021.
- Business Quant data shows INVA's Interest & Investment Income at $503000.0 in Q3 2021, $20000.0 in Q2 2021, and $30000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Innoviva | 1.59 Bn | 983.20 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 503,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 30,000.00 |
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | 41,000.00 |
| Jun 30, 2020 | 158,000.00 |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | 1.54 Mn |
| Sep 30, 2019 | 1.62 Mn |
| Jun 30, 2019 | 1.40 Mn |
| Mar 31, 2019 | 975,000.00 |
| Dec 31, 2018 | 519,000.00 |
| Sep 30, 2018 | 370,000.00 |
| Jun 30, 2018 | 380,000.00 |
| Mar 31, 2018 | 391,000.00 |
| Dec 31, 2017 | 393,000.00 |
| Sep 30, 2017 | 376,000.00 |
| Jun 30, 2017 | 306,000.00 |
| Mar 31, 2017 | 236,000.00 |
| Dec 31, 2016 | 171,000.00 |